In the original article, there was a mistake regarding references in Table 1 as published. The corrected Table 1 appears below.
Table 1
| References | Age at Tx | Procedure | Follow-up | Metabolic decompensation/crisis time | MMA level (P/CSF: nmol/mL U:μmol/mmol Cr) | Dietary protein (g/kg/d) | Neurological damage/ DQ | Renal dysfunction (eGFR:mL/min/1.73 m2 | Developmental delay/SD of height | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | ||||
| Kaplan et al. (27) | 19 m | OLT | 10 y | Y | Y (only twice) | P:574 ± 431 | P:220 ± 79 | 1.7 | NA | Increased subarachnoid space | Acute lesion in right globus pallidus, then resolved& | N | eGFR = 77 | Between the 25th and 50th percentiles | −2SD |
| U:9307 ± 4923 | U:3656 ± 2271 | ||||||||||||||
| CSF: 1103 | CSF:901 ± 263 | ||||||||||||||
| Mc Guire et al. (21) | 5 y | CKLT (OLT) | 10 m | Y | N | P:20–2591 | P:25–525 | 1.95 | NA | Y (cerebellar stroke) | Y | Y | N | Failure to thrive | NA |
| U:1101–13962 | U:116–1895 | ||||||||||||||
| Chen et al. (19) | 0.9–2.1 y | LDLT (n = 4) | 0.2–7.7 y | 2.73/y | 0.08/y | P:87.5–204 | P:63.2–87 | 0.66–1.00 | 1.37–2.80 | NA | NA | N | N | Development all continued | |
| Morioka et al. (15) Kamei et al. (16) | 7–90 m | LDLT (n = 7) | 19–53 m | Y | N | P:268.0 | P:99.4 | 1.0 | 3.0 | The global cognitive index of the McCarthy scale and the Denver development quotient were improved but did not reach normal values | N | N | −2 | −2 | |
| P:47.0 | P:59.2 | 1.2 | 2.5 | N | N | −2 | −2 | ||||||||
| P:143.0 | P:36.4 | 0.7 | 2.5 | N | N | −3.14 | −2 | ||||||||
| P:39.0 | P:29.3 | 2.0 | 3.0 | N | N | −2 | −1 | ||||||||
| P:375.0 | P:87.8 | 1.0 | 2.5 | N | N | −1.3 | −0.6 | ||||||||
| P:1970.0 | P:232.0 | –# | – | Y | – | – | – | ||||||||
| P:166.0 | P:13.8 | 1.5 | 2.5 | N | N | −3 | −2 | ||||||||
| LDLT (n = 3) | P:278.0 | P:59.6 | NA | NA | NA | NA | N | N | NA | NA | |||||
| P:702.0 | P:124.4 | ||||||||||||||
| P:255.0 | P:8.5 | ||||||||||||||
| Vernon et al. (29) | 28 y | CKLT | 18 m | Y | N | P: 6965 ± 1638 | P:234 ± 100 | Restricted | Not restricted | Optic neuropathy, leukoencephalopathy | Stable visual function, tremor persists | Y | N | Worsening generalized debility | Able to walk |
| Spada et al. (28) | 3 y | Whole LT | 12 y | Y | N | P: sustained (~80%) and stable reduction | 0.8 | 1.5 | Normal intellectual development | N | Y | NA | NA | ||
| 9 m | Split-LT | 2 y | Y | N | P:124.4 | P:43.5 | 0.8 | 1.8 | Adequate neurologic development | N | N | NA | NA | ||
| Niemi et al. (18) | Mean 8.2 y (0.8–20.7) | LT* (n = 6) CKLT (n = 8) | Mean 3.25 ± 4.2 y | Y | N | P:1648 ± 1492 | P:305 ± 108 | 1.6 (Natural protein 0.3–1.9) | 1.6 (Natural protein 0.6–1.8) | Maintained neurodevelopmental abilities | Y (n = 8) | N | Present in 12 patients (86%) | Maintained or improved | |
| Khanna et al. (24) | 28 y | OLT (domino donor) | 11 m | Y | N | P:445.9 ± 257.0 | P:333.3 ± 117.7 | Y | 1.0–1.9 (liberalized) | Increasing neurologic disability | NA | >60 | 51.0 ± 12.1†| Altered gait, and slower speech | NA |
| U:5277 ± 1968 | U:1068 ± 384 | ||||||||||||||
| Sakamoto et al. (20) | 7 y | LDLT (n = 13) | 4–16 y (mean 8.1 y) | 0 | 0 | P: ~75–240 (mean) | P: ~5–170 (mean) | 1.2 | Less | 41 | 53 | N | N | −2.0 | −2.0 |
| 5 y | 3 | 0 | 0.7 | Less | 43 | 48 | N | N | −3.1 | −2.0 | |||||
| 1 y | 3 | 0 | 1.5 | 1.65–1.8 | 49 | 54 | N | N | −3.0 | −2.0 | |||||
| 8 m | 1 | 0 | 1.2 | 1.3 | NA | 32 | N | N | −2.8 | −0.2 | |||||
| 11 m | 3 | 1 | 0.9 | 1.5 | 55 | 48 | N | N | −1.4 | −1.8 | |||||
| 5 y | 5 | 5 | 1.7 | 0.95 | NA | 23 | N | N | −4.3 | −4.4 | |||||
| 10 m | 2 | 0 | 1.5 | 1.0–1.5 | 63 | 55 | N | N | −2.5 | −1.3 | |||||
| 12 m | 2 | 0 | 0.7 | 1.0–1.5 | 57 | 42 | N | N | −2.5 | −1.7 | |||||
| 9 m | 3 | 2 | 1.3 | 1.0 | NA | NA | N | N | −3.2 | −0.6 | |||||
| 8 m | 1 | 0 | 1.3 | 1.2 | NA | NA | N | N | 1.5 | 0.8 | |||||
| 2 y | 3 | 0 | 1.0 | 1.0–1.5 | 60 | 54 | Y | Y※ | −3.6 | −1.9 | |||||
| 2 y | 5 | 1 | 2.0 | 1.0–1.5 | NA | NA | N | N | −3.6 | −3.2 | |||||
| 10 m | 1 | 0 | 1.5 | Not restricted | 70 | NA | N | N | −0.7 | 0.0 | |||||
| Critelli et al. (23) | 6.6 y | Kidney/split liver | 3.1 y | Y | N | P: 745 (mean) | P: 154.9 (mean) | 1.6–2.0 | 1 | NA | NA | 56 | 78 | Mild | NA |
| 21.6 y | CKLT | 1.6 y | Y | N | 1.45–1.75 | 1.0–1.1 | 40 | 70 | Extremely low to borderline | ||||||
| 7.4 y | CKLT | 4.1 y | Y | N | 1.6–2.0 | 1.43 | 66.2 | 142 | Moderate to severe | ||||||
| 15.5 y | CKLT | 11.6 y | Y | N | 1.3 | 0.76–0.95 | 40 | 68§ | Mild | ||||||
| 9.4 y | CKLT | 3.6 y | Y | N | 0.98–1.18 | 1.3–1.5 | 65 | 88 | No formal testing | ||||||
| 1.9 y | OLT | 1 y | Y | N | 0.83 | 1.0–1.2 | 96.8 | 128 | Borderline | ||||||
Outcomes of LT/CKLT for patients with MMA.
NA, not available; OLT, orthotopic liver transplantation; LDLT, living donor liver transplantation.
72 days post-transplantation, MRI with diffusion-weighted imaging of brain demonstrated an acute lesion in the right globus pallidus but has never manifested clinical signs of extrapyramidal tract disease. Subsequent MRI 18 months later showed resolution of the basal ganglion lesion.
Died of sepsis on postoperative day 44.
One underwent liver retransplantation because of hepatic artery thrombosis.
The postoperative period was complicated by acute kidney injury. The renal function improved progressively.
Acute renal failure occurred after using contrast medium for endoscopic retrograde cholangiopancreatography.
Underwent a renal biopsy 17 months after CLKT, which showed mild tubulointerstitial injury.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
methylmalonic acidemia, methylmalonic acid, liver transplantation, metabolic, decompensation
Citation
Jiang Y-Z and Sun L-Y (2020) Corrigendum: The Value of Liver Transplantation for Methylmalonic Acidemia. Front. Pediatr. 8:126. doi: 10.3389/fped.2020.00126
Received
05 December 2019
Accepted
09 March 2020
Published
02 April 2020
Volume
8 - 2020
Edited by
Jürgen Schleef, IRCCS Materno Infantile Burlo Garofolo (IRCCS), Italy
Reviewed by
Mark Joseph Holterman, Independent Researcher, Warrenville, IL, United States
Updates
Copyright
© 2020 Jiang and Sun.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Li-Ying Sun sunxlx@outlook.com
This article was submitted to Pediatric Surgery, a section of the journal Frontiers in Pediatrics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.